bitop AG, located in Witten, Germany, is the only company worldwide able to isolate and produce Ectoin® in quantities suitable for supplying the market. The company develops and markets Ectoin®-containing medical devices for different therapeutic areas such as asthma, COPD, allergy, and dermatology. Inhalation medical devices containing Ectoin® are developed for nebulizer (inhalation solution) or dry powder inhaler (DPI) application and are a near-tomarket opportunity for health care companies seeking a partnership for the indications asthma and COPD. The company has its roots in the area of bioprocessing as well as the cultivation and utilization of extremophilic microorganisms.